Isaac Health Introduces New Virtual Program to Reduce Dementia Risk
Isaac Health launched an eight-week virtual program to help people reduce dementia risk through lifestyle changes like sleep, nutrition and exercise.
Isaac Health launched an eight-week virtual program to help people reduce dementia risk through lifestyle changes like sleep, nutrition and exercise.
NYU Langone Health is partnering with Isaac Health to launch a specialist-led virtual care model aimed at reducing long waits for memory care. The partnership will test whether telehealth can expand access without sacrificing quality as demand for neurologists continues to outpace supply.
The solution isn't about creating more referral pathways, but about building the measurement infrastructure that enables excellent primary care providers to act confidently on their observations.
New tools and evidence can empower early action against Alzheimer’s before symptoms strike
Time is of the essence, particularly for those with cognitive conditions. The loss of telehealth flexibilities, combined with disruptions to Medicaid, could have devastating consequences for millions of patients with dementia and other cognitive and behavioral conditions.
NewDays' $7 million seed round was led by General Catalyst and Madrona. The funds will be used to expand into additional states and grow its team.
Small practices play a critical role in healthcare delivery, but they cannot continue to absorb ever-increasing administrative demands without consequences.
Much of today’s care infrastructure was built for a different era, when medicine focused on acute illnesses and short-term fixes. But neurodegenerative diseases don’t follow that script, and neither can we. We have the tools to build something better: care that stays with people, adapts to their needs, and helps them live not just longer, but better.
Isaac Health, a startup specializing in cognitive care for Alzheimer’s dementia , raised $10.5 million in Series A funding to expand nationwide access to its platform. The company partners with health plans to provide screening, specialist diagnosis, treatment, and ongoing management aimed at slowing cognitive decline.
As the pool of approved therapies continues to (hopefully) expand, the clinical and diagnostic testing communities need to do a better job at ensuring the right patients move through this journey more quickly – and accurately – to improve their health and prognosis.
While advancements in diagnostics are promising, the need remains for healthcare professionals to take the lead on proactive conversations with patients and their loved ones about the early signs and symptoms of Alzheimer’s disease.
Enterprise EHR boosts scalability, interoperability, and governance for large healthcare systems.
Early diagnosis through blood tests buys invaluable time – for patients and their families to plan, seek support, make informed decisions about their difficult care journey and, perhaps most importantly, be together.
Wearable technology seems to offer great potential for early detection and management of agitation experienced by people with communication-impaired neurological disorders, allowing caregivers to provide personalized interventions that could significantly improve patients’ lives.
In-home hospice care, which gives them ample opportunities to engage with family and friends in the comfort of their own homes, allows providers to give dementia patients the daily contact they deserve.
Many women going through menopause suffer brain fog, but some may be worried about a more serious cognitive condition like dementia. Because of this, Midi Health and Neurotrack partnered to offer a cognitive assessment to patients.
GUIDE — Guiding an Improved Dementia Experience — is the new dementia care model from the CMS and the CMMI (Centers for Medicare and Medicaid Innovation) for beneficiaries covered by traditional fee-for-service (FFS) Medicare and their caregivers. It represents an incremental step forward in managing neurodegenerative diseases effectively.